Form 4: Intuitive Surgical Director Sells Shares After Option Exercise

Intuitive Surgical Director Craig H. Barratt exercised stock options and sold the resulting shares under a Rule 10b5-1 plan.

Summary

• Director Craig H. Barratt exercised 750 non-qualified stock options for Intuitive Surgical Inc. (ISRG) common stock on November 12, 2025.
• The exercise price for these options was $71.3233 per share.
• Immediately following the exercise, Barratt sold all 750 shares of common stock at a price of $580 per share.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which is set to expire on April 29, 2026.
• Following these transactions, Barratt directly owns 0 shares of common stock, but indirectly holds 27,198 shares through a Trust.
• The non-statutory stock option was granted pursuant to the Non-Employee Directors' Stock Option Plan and vests 100% one year after the grant date or at the next Shareholders Meeting, whichever occurs first, provided service to the Company continues.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While a director selling shares can be seen negatively, the transaction was pre-planned under a 10b5-1 plan, indicating no new negative information. The significant gain realized from the option exercise reflects positively on the company's stock performance over time.

Positives

• The transactions were conducted under a Rule 10b5-1 trading plan, indicating a pre-planned sale not based on new, undisclosed inside information.
• The director realized a significant gain by exercising options at $71.3233 and selling shares at $580, reflecting strong historical stock performance for Intuitive Surgical.

Negatives

• A director selling shares, even if pre-planned, can sometimes be perceived negatively by the market, though the context of a 10b5-1 plan mitigates this concern.
• The director's direct beneficial ownership of common stock is now 0 shares, although substantial indirect ownership through a trust remains.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on an insider's stock transactions.

Industry Context

This Form 4 filing reports an individual director's stock transactions, which is a routine disclosure for publicly traded companies. It does not provide information directly related to broader industry trends or competitive landscape, but reflects an insider's personal portfolio management within the medical device sector.

Comparison to Industry Standards

• The reported transaction is a standard Form 4 filing for an insider stock option exercise and sale, common across all industries for executive compensation and personal financial management.
• The substantial difference between the option exercise price ($71.3233) and the sale price ($580) indicates significant stock appreciation, which is a positive indicator of Intuitive Surgical's performance over the period the options were held, aligning with strong performers in the medical device and technology sectors.
• No specific comparable companies or projects are detailed within this transaction report to provide a direct benchmark.

Related Party Transactions

• Director Craig H. Barratt, an insider, exercised stock options and sold shares of the company's common stock.
• 27,198 shares are indirectly owned by a Trust, which is a related party to the director.

Stakeholder Impact

• Shareholders: The sale by a director might be viewed with slight caution, but the pre-planned nature under a Rule 10b5-1 plan mitigates concerns about new negative information. The significant profit from the option exercise suggests good past stock performance.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this transaction report.

Key Dates

Recommendation

This Form 4 reports a routine, pre-planned transaction by a director under a Rule 10b5-1 plan, involving the exercise of stock options and subsequent sale of shares. Such transactions are typically for personal financial management and do not usually signal a change in the company's fundamental outlook or the director's confidence. The significant profit realized from the option exercise reflects positively on the company's historical stock performance. Without additional information regarding company performance or strategic shifts, the filing itself does not warrant a change from a 'hold' position.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Director Transaction, Rule 10b5-1